Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Newer and upcoming therapies for melasma.

Sarkar R, Chugh S, Garg VK.

Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):417-28. doi: 10.4103/0378-6323.98071. Review.

2.

Advances in the treatment of melasma: a review of the recent literature.

Ball Arefiev KL, Hantash BM.

Dermatol Surg. 2012 Jul;38(7 Pt 1):971-84. doi: 10.1111/j.1524-4725.2012.02435.x. Epub 2012 May 14. Review.

PMID:
22583339
3.

Melasma. Etiologic and therapeutic considerations.

Grimes PE.

Arch Dermatol. 1995 Dec;131(12):1453-7. Review.

PMID:
7492140
4.

Utilizing combination therapy to optimize melasma outcomes.

Rendon MI.

J Drugs Dermatol. 2004 Sep-Oct;3(5 Suppl):S27-34. Review.

PMID:
15552597
5.

The treatment of melasma: a review of clinical trials.

Gupta AK, Gover MD, Nouri K, Taylor S.

J Am Acad Dermatol. 2006 Dec;55(6):1048-65. Epub 2006 Sep 28. Review.

PMID:
17097400
6.

Treatment of melasma.

Rendon M, Berneburg M, Arellano I, Picardo M.

J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S272-81. Review.

PMID:
16631968
7.

Melasma: treatment strategy.

Sehgal VN, Verma P, Srivastava G, Aggarwal AK, Verma S.

J Cosmet Laser Ther. 2011 Dec;13(6):265-79. doi: 10.3109/14764172.2011.630088. Review.

PMID:
21981383
8.

Treatment of melasma with topical agents, peels and lasers: an evidence-based review.

Rivas S, Pandya AG.

Am J Clin Dermatol. 2013 Oct;14(5):359-76. doi: 10.1007/s40257-013-0038-4. Review.

PMID:
23881551
9.

Management of hyperpigmentation in darker racial ethnic groups.

Grimes PE.

Semin Cutan Med Surg. 2009 Jun;28(2):77-85. doi: 10.1016/j.sder.2009.04.001. Review.

PMID:
19608057
10.

Melasma.

Lee BW, Schwartz RA, Janniger CK.

G Ital Dermatol Venereol. 2017 Feb;152(1):36-45. doi: 10.23736/S0392-0488.16.05425-0. Epub 2016 Sep 2. Review.

PMID:
27589484
11.

Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients.

Stratigos AJ, Katsambas AD.

Am J Clin Dermatol. 2004;5(3):161-8. Review.

PMID:
15186195
12.

Facial melanoses: Indian perspective.

Khanna N, Rasool S.

Indian J Dermatol Venereol Leprol. 2011 Sep-Oct;77(5):552-63; quiz 564. doi: 10.4103/0378-6323.84046. Review.

13.
14.

Management of facial hyperpigmentation.

Pérez-Bernal A, Muñoz-Pérez MA, Camacho F.

Am J Clin Dermatol. 2000 Sep-Oct;1(5):261-8. Review.

PMID:
11702317
15.

Melasma: clinical diagnosis and management options.

Rodrigues M, Pandya AG.

Australas J Dermatol. 2015 Aug;56(3):151-63. doi: 10.1111/ajd.12290. Epub 2015 Mar 9. Review.

PMID:
25754098
16.

New and experimental treatments of cloasma and other hypermelanoses.

Picardo M, Carrera M.

Dermatol Clin. 2007 Jul;25(3):353-62, ix. Review.

PMID:
17662901
17.

Hyperpigmentation and melasma.

Rigopoulos D, Gregoriou S, Katsambas A.

J Cosmet Dermatol. 2007 Sep;6(3):195-202. Review.

PMID:
17760699
18.

Melasma in men.

Vachiramon V, Suchonwanit P, Thadanipon K.

J Cosmet Dermatol. 2012 Jun;11(2):151-7. doi: 10.1111/j.1473-2165.2012.00613.x. Review.

PMID:
22672280
19.

Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.

Sofen B, Prado G, Emer J.

Skin Therapy Lett. 2016 Jan;21(1):1-7. Review.

20.

Melasma.

Wu IB, Lambert C, Lotti TM, Hercogová J, Sintim-Damoa A, Schwartz RA.

G Ital Dermatol Venereol. 2012 Aug;147(4):413-8. Review.

PMID:
23007216

Supplemental Content

Support Center